Mammary tumors from control offspring had higher expression of Cdh1 before treatment, compared with TAM-treated (P = 0.005) and recurring tumors (P = 0.022; 2-way ANOVA for interaction: P = 0.003). Here, CDH1 is linked to breast cancer.